Selected items from the News and Latest Additions sections of www.palliativedrugs.com [link], the world’s leading palliative care website. Drug updates Crush resistant formulation of oxymorphone approved in US The US Food and Drug Administration (FDA) have approved a crush resistant formulation of oxymorphone aimed at reducing abuse potential. The company (Endo Pharmaceuticals, Chadds Ford, Pennsylvannia, […]
Latest articles
SHORTCUTS
Articles of interest in other scholarly journals Click on the article headings to view abstracts Physicians’ self-assessment of cancer pain treatment skills-more training required. Silvoniemi M, Vasankari T, Vahlberg T, Vuorinen E, Clemens KE, Salminen E. In this study 720 Finnish physicians (59 oncologists) had their perception on their skills and training needs on palliative […]
Studies of interest in Supportive and Palliative care on the CancerHelp UK clinical trials database
Introduction Do your cancer patients ever ask you about clinical trials? If so, you could show them the CancerHelp UK clinical trials database (http://cancerhelp.cancerresearchuk.org/trials/trials-search/) which is part of the comprehensive patient information website of Cancer Research UK. This unique service was started over 10 years ago and provides information about UK cancer trials and studies, […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety updates MHRA warns against Butterbur herbal remedies The UK Medicines and Healthcare products Regulatory Agency (MHRA) has warned people not to take Butterbur (Petasites hybridus) herbal remedies due to the risk of hepatic toxicity. Products containing butterbur […]
Rising numbers of children in England require palliative care
A new study by researchers at Leeds University has found that the number of children in England who have life-limiting conditions (LLCs) is not only much higher than previously thought but also increasing. Historically, the number of children requiring or receiving palliative care in England has been under-estimated due to the fact that there is […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot Topics EAPC guidelines on the use of opioid analgesics for cancer pain An updated version of the guidelines of the European Association for Palliative Care (EAPC) on the use of opioids for the treatment of cancer pain […]
Beyond Pain Relief: Non-Pharmacological Care Activities in Palliative Care
Professionals who care for people at the end of life do much more than prescribe drugs, a new study has shown. The qualitative analysis published last month in the journal PLoS Medicine revealed that the day-to-day activities of palliative caregivers throughout Europe are highly multifaceted and complex. The study used qualitative research methods to identify […]
SHORTCUTS
Articles of interest in other scholarly journals Click on the article headings to view abstracts Undetected Cognitive Impairment and Decision-Making Capacity in Patients Receiving Hospice Care. Burton CZ, Twamley EW, Lee LC, Palmer BW, Jeste DV, Dunn LB, Irwin SA. This study examined the prevalence of cognitive impairment and its impact on decision-making abilities in […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates Extemporaneous thalidomide oral suspension stability study A stability study of thalidomide oral suspension 20mg/mL, using the contents of oral thalidomide capsules and a 1:1 mixture of Ora-Plus and Ora-Sweet, has been published. The HPLC method demonstrated […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com , the world’s leading palliative care website. Safety updates Citalopram and escitalopram maximum daily doses restricted Restrictions on the maximum daily doses of citalopram and escitalopram have been made following the evaluation of a QT study by the UK Medicines and Healthcare products Regulatory […]